Sun Pharma Advanced Research Company Limited (SPARC) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.00x

Sun Pharma Advanced Research Company Limited (SPARC) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs63.20 Million. Explore SPARC capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Rs0.00
Capex + Investments

Operating Cash Flow

Rs63.20 Million
INR

Capital Expenditures

Rs0.00
INR

Sun Pharma Advanced Research Company Limited Cash Flow Reinvestment Rate (2009–2014)

Historical reinvestment intensity for Sun Pharma Advanced Research Company Limited across 4 annual periods. Also explore total assets of Sun Pharma Advanced Research Company Lim for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Sun Pharma Advanced Research Company Limited (2009–2014)

Year-by-year capital reinvestment analysis for Sun Pharma Advanced Research Company Limited. For live market cap and broader valuation context, see market cap of Sun Pharma Advanced Research Company Lim.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2014 2.68x Rs987.15 Million Rs368.95 Million Rs36.74 Million ▲ +41.6%
2011 1.89x Rs47.34 Million Rs25.05 Million Rs47.34 Million ▲ +191.8%
2010 0.65x Rs81.83 Million Rs126.34 Million Rs81.83 Million ▼ -37.2%
2009 1.03x Rs262.35 Million Rs254.54 Million Rs262.35 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow